By Professor David Thomas

Journal articles

Gold LS; De Roos AJ; Ray RM; Wernli K; Fitzgibbons ED; Gao D-L; Astrakianakis G; Feng Z; Thomas D; Checkoway H, 2006, 'Brain tumors and occupational exposures in a cohort of female textile workers in Shanghai, China.', Scand J Work Environ Health, 32, pp. 178 - 184, http://dx.doi.org/10.5271/sjweh.996

Cullinane C; Dorow DS; Kansara M; Conus N; Binns D; Hicks RJ; Ashman LK; McArthur GA; Thomas DM, 2005, 'An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development', Cancer Research, 65, pp. 9633 - 9636, http://dx.doi.org/10.1158/0008-5472.CAN-05-2285

Dudley AC; Thomas D; Best J; Jenkins A, 2005, 'A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia', Biochemical Journal, 390, pp. 427 - 436, http://dx.doi.org/10.1042/BJ20050351

Morgan T; Atkins GJ; Trivett MK; Johnson SA; Kansara M; Schlicht SL; Slavin JL; Simmons P; Dickinson I; Powell G; Choong PFM; Holloway AJ; Thomas DM, 2005, 'Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor κB', American Journal of Pathology, 167, pp. 117 - 128, http://dx.doi.org/10.1016/S0002-9440(10)62959-8

Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DDL; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW, 2004, 'Terminal osteoblast differentiation, mediated by runx2 and p27 KIP1, is disrupted in osteosarcoma', Journal of Cell Biology, 167, pp. 925 - 934, http://dx.doi.org/10.1083/jcb.200409187

Thomas DM; Fleming NI; Holloway AJ; Bowtell DDL, 2004, 'Molecular medicine: A clinician's primer on microarrays', Internal Medicine Journal, 34, pp. 565 - 569, http://dx.doi.org/10.1111/j.1445-5994.2004.00680.x

Dudley AC; Thomas D; Best J; Jenkins A, 2004, 'The STATs in cell stress-type responses', Cell Communication and Signaling, 2, http://dx.doi.org/10.1186/1478-811X-2-8

Dudley A; Gilbert RE; Thomas D; Cox A; Price JT; Best J; Jenkins A, 2003, 'STI-571 inhibits in vitro angiogenesis', Biochemical and Biophysical Research Communications, 310, pp. 135 - 142, http://dx.doi.org/10.1016/j.bbrc.2003.08.129

Chin SL; Johnson SA; Quinn J; Mirosavljevic D; Price JT; Dudley AC; Thomas DM, 2003, 'A role for αV integrin subunit in TGF-β-stimulated osteoclastogenesis', Biochemical and Biophysical Research Communications, 307, pp. 1051 - 1058, http://dx.doi.org/10.1016/S0006-291X(03)01294-4

Thomas DM; Yang HS; Alexander K; Hinds PW, 2003, 'Role of the retinoblastoma protein in differentiation and senescence', Cancer Biology and Therapy, 2, pp. 124 - 130, http://dx.doi.org/10.4161/cbt.2.2.235

Dudley A; McKinstry W; Thomas D; Best J; Jenkins A, 2003, 'Removal of endotoxin by reverse phase HPLC abolishes anti-endothelial cell activity of bacterially expressed plasminogen kringle 5', Biotechniques, 35, pp. 724 - 732, http://dx.doi.org/10.2144/03354st02

Cook N; Thomas DM, 2002, 'Retrospective survey of unselected hospital patients with and without cancer comparing outcomes following venous thromboembolism', Internal Medicine Journal, 32, pp. 437 - 444, http://dx.doi.org/10.1046/j.1445-5994.2002.00249.x

Rosenthal MA; Thomas D; Davis I; Toner G; Noordin N; Zalcberg J, 2001, 'Pilot study of oral eniluracil/5-FU in the palliation of hormone-refractory prostate cancer', Prostate Journal, 3, pp. 30 - 35, http://dx.doi.org/10.1046/j.1525-1411.2001.003001030.x

Thomas DM; Carty SA; Piscopo DM; Lee JS; Wang WF; Forrester WC; Hinds PW, 2001, 'The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation', Molecular Cell, 8, pp. 303 - 316, http://dx.doi.org/10.1016/S1097-2765(01)00327-6

Zelzer E; Glotzer DJ; Hartmann C; Thomas D; Fukai N; Soker S; Olsen BR, 2001, 'Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2', Mechanisms of Development, 106, pp. 97 - 106, http://dx.doi.org/10.1016/S0925-4773(01)00428-2

Li HQ; Thomas DB; Berry G; MacLennan R; Shearman R; Jelihovsky T; Booth JC; Molina R; Martinez L; Salas O; Dabancens A; Cuadros A; Aristizabal N; Berry G; Modan B; Ron E; Alfandary E; Mati JG; Kenya P; Kungu A; Gatei D; Cuevas HR; Salazar SB; Palet A; Ontiveros P; Apelo RA; De la Cruz JR; Baens J; Canlas BD; Silpisornkosol S; Pardthaisong T; Charoeniam V; Theetranont C; Boosiri B; Chutivongse S; Virutamasen P; Wongsrichanalai C; Sindhavananda S; Koetsawang S; Rachawat D; Koetsawang A; Riotton G; Christopherson WM; Melnick JL; Adam E; Meirik O; Farley TMM; Holck S, 2000, 'Tubal ligation and risk of cervical cancer', Contraception, 61, pp. 323 - 328, http://dx.doi.org/10.1016/S0010-7824(00)00111-6

Puche RC; Thomas DM; Udagawa N; Hards DK; Quinn JMW; Moseley JM; Findlay DM; Best JD, 1999, 'Letters to the editor (multiple letters).', Bone, 25, pp. 251, http://dx.doi.org/10.1016/s8756-3282(99)00159-3

Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP, 1999, 'Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation', Journal of Bone and Mineral Research, 14, pp. 342 - 350, http://dx.doi.org/10.1359/jbmr.1999.14.3.342

Thomas DM; Ferguson GD; Herschman HR; Elferink LA, 1999, 'Functional and Biochemical Analysis of the C2 Domains of Synaptotagmin IV', Molecular Biology of the Cell, 10, pp. 2285 - 2295, http://dx.doi.org/10.1091/mbc.10.7.2285

Williamson PA; Thomas DM; Beasley P, 1999, 'Posterior tragal perichondrium harvesting for myringoplasty', CLINICAL OTOLARYNGOLOGY, 24, pp. 252 - 254, http://dx.doi.org/10.1046/j.1365-2273.1999.00246.x

Ferguson GD; Thomas DM; Elferink LA; Herschman HR, 1999, 'Synthesis degradation, and subcellular localization of synaptotagmin IV, a neuronal immediate early gene product.', J Neurochem, 72, pp. 1821 - 1831, http://dx.doi.org/10.1046/j.1471-4159.1999.0721821.x

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Correction: Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer (Medical Journal of Australia (1998) 169 (227))', Medical Journal of Australia, 169, pp. 344

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer (vol 169, pg 227, 1998)', MEDICAL JOURNAL OF AUSTRALIA, 169, pp. 344 - 344, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076023200028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomas DM; Udagawa N; Hards DK; Quinn JMW; Moseley JM; Findlay DM; Best JD, 1998, 'Insulin receptor expression in primary and cultured osteoclast-like cells', Bone, 23, pp. 181 - 186, http://dx.doi.org/10.1016/S8756-3282(98)00095-7

Thomas DM; Zalcberg JR, 1998, '5-Fluorouracil: A pharmacological paradigm in the use of cytotoxics', Clinical and Experimental Pharmacology and Physiology, 25, pp. 887 - 895, http://dx.doi.org/10.1111/j.1440-1681.1998.tb02339.x

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer [1]', Medical Journal of Australia, 169, pp. 227, http://dx.doi.org/10.5694/j.1326-5377.1998.tb140229.x

Thomas DM; Seymour JF; Szer J; Grigg AP; Basser RL; Green MD; Fox RM; Thomas DM, 1998, 'Progress in management of acute myeloid leukaemia (AML) in Australia since 1980: A single institution retrospective study', Australian and New Zealand Journal of Medicine, 28, pp. 190 - 196, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02968.x

Thomas DM; Ng KW; Best JD, 1997, 'Insulin and bone: A clinical and scientific review', Endocrinology and Metabolism Supplement, 4, pp. 5 - 17

Thomas DM; Seymour JF; Griffiths JD; Szer J; Grigg AP, 1997, 'Prolonged disease-free survival with specific re-induction therapy in acute myeloid leukaemia relapsing following bone marrow transplantation', Australian and New Zealand Journal of Medicine, 27, pp. 712 - 713, http://dx.doi.org/10.1111/j.1445-5994.1997.tb01009.x

Thomas DM; Maher F; Rogers SD; Best JD, 1996, 'Expression and regulation by insulin of Glut 3 in UMR 106-01, a clonal rat osteosarcoma cell line', Biochemical and Biophysical Research Communications, 218, pp. 789 - 793, http://dx.doi.org/10.1006/bbrc.1996.0140

Thomas DM; Rogers SD; Ng KW; Best JD, 1996, 'Dexamethasone modulates insulin receptor expression and subcellular distribution of the glucose transporter GLUT 1 in UMR 106-01, a clonal osteogenic sarcoma cell line', Journal of Molecular Endocrinology, 17, pp. 7 - 17, http://dx.doi.org/10.1677/jme.0.0170007

Thomas DM; Hards DK; Rogers SD; Ng KW; Best JD, 1996, 'Insulin receptor expression in bone', Journal of Bone and Mineral Research, 11, pp. 1312 - 1320, http://dx.doi.org/10.1002/jbmr.5650110916

Thomas DM; Rogers SD; Sleeman MW; Pasquini GM; Bringhurst FR; Ng KW; Zajac JD; Best JD, 1995, 'Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line', Journal of Molecular Endocrinology, 14, pp. 263 - 275, http://dx.doi.org/10.1677/jme.0.0140263

Prentice RL; Thomas D, 1993, 'Methodologic research needs in environmental epidemiology: data analysis.', Environmental Health Perspectives, 101, pp. 39 - 48, http://dx.doi.org/10.1289/ehp.93101s439

Severson RK; Stevens RG; Davis S; Thomas D; Heuser L; Sever LE, 1989, 'THE AUTHORS REPLY', American Journal of Epidemiology, 130, pp. 425 - 427, http://dx.doi.org/10.1093/oxfordjournals.aje.a115352

Conference Papers

Harris S; Gaughran G; Napier C; Yap M; Grady J; Caillet V; Ballinger M; Kee D; Thavaneswaran S; Davies A; Southi N; Thomas D, 2025, 'KRAS Mutations in Australian Gastrointestinal Cancer Patients: An Analysis of the Molecular Screening and Therapeutics (MoST) Program', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY

Zeglinas N; Nott L; Tay R; Thomas D, 2025, 'Real-World Trends, Rural-Urban Differences, and Socioeconomic Disparities in Access to and Utilisation of Tumour Genomic Profiling within a Tasmanian Population', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY

Thomas DM; Daniele G; Kim JE; Gadgeel SM; Ahn ER; Paz-Ares LG; Prenen H; Chen D; Fang J; Wilson TR; Simmons BP; Barlesi F, 2024, 'Ipatasertib in patients with AKT1/2/3 mutation-positive (AKTmut) tumors: TAPISTRY study', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Special Clinical Science Symposia, ELECTR NETWORK, 29 May 2024 - 29 May 2024

Murray S; Meacham G; Irwin S; Rao V; Rolt J; Dimitriadis S; Dooley K; Heslington A; Goodyear C; Siebert S; Mcinnes I; Willicombe M; Thomas D; Billingham L; Kearns P; Marjot T; Kronsteiner B, 2024, 'Multi-omic immunophenotyping to identify predictors of mRNA vaccine responsiveness in immunocompromised individuals', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, IL, Chicago, presented at Annual Meeting of the American-Association-of-Immunologists (IMMUNOLOGY), IL, Chicago, 03 May 2024 - 07 May 2024, http://dx.doi.org/10.4049/jimmunol.212.supp.1550.4167

Harris S; Caillet V; Davies A; Gaughran G; Napier C; Lin F; Simes J; Grady J; Balinger M; Thomas D, 2024, 'Prevalence and co-mutation status of MTAP deletions', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116

McNamee N; Lin F; Sim H-W; Napier C; Thomas D; Simes J; Thavaneswaran S, 2023, 'EXPLORING THE PROGNOSTIC IMPLICATIONS OF MOLECULAR ALTERATIONS IN ASTROCYTOMAS USING COMPREHENSIVE GENOMIC PROFILING (CGP)', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, CANADA, Vancouver, presented at 28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO), CANADA, Vancouver, 15 November 2023 - 19 November 2023

Zeverijn LJ; Looze E; Thavaneswaran S; Henegouwen JMVB; Simes J; Hoes LR; Geurts B; Sebastian L; Roepman P; Lin FP-Y; Jansen AML; de Leng WWJ; van der Noort V; Leek LVM; de Vos FYFL; Verheul HMW; Gelderblom H; Thomas DM; Voest EE; Sjoquist KM, 2023, 'Clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023

Zaheed M; Napier CE; Cops EJ; Ferris N; Moodie K; Milner B; Moses D; Poplawski N; Dow EG; Harris M; Tucker K; Trainer A; James P; Thomas DM; Ballinger ML, 2023, 'Long-term clinical and psychosocial outcomes of surveillance in Li Fraumeni syndrome.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023

Pavlakis N; Millward M; Richardson G; Andelkovic V; Kichenadasse G; Thomas DM; Fernandez AM; Thakkar D; Arbabzade T; Goey CH; Seet Q; Toy W; Paszkiewicz K; Ingram PJ; Boyd-Kirkup JD; Kwek KY, 2023, '88TiP A phase Ib study of HMBD-001, a monoclonal antibody targeting HER3, with or without chemotherapy in patients with genetic aberrations in HER3 signaling', in Annals of Oncology, Elsevier, pp. s1501, http://dx.doi.org/10.1016/j.annonc.2023.10.788

Thomas D; Miften M; Kavanagh B; Jones B, 2023, 'Computer Vision Assisted Collision Avoidance for Radiation Therapy', in AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, LIPPINCOTT WILLIAMS & WILKINS, pp. S82 - S82

Thomas DM, 2022, 'A population-based, whole genome sequencing approach to mapping the genetic basis of mesenchymal malignancies', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH

Scott CL; Lim R; Kee D; Georgiou C; Caldwell R; Papadopoulos L; Krasovitsky MS; Tay R; Bourne A; Vandenberg C; Dall G; Shield-Artin K; Carmagnac A; Ratnayak G; Tram J; Zhou W; Bedo J; Penington J; Zhu L; Vissers J; Thomas D; Grimmond S; Wakefield M; Papenfuss T; Barke H; Goldstein D, 2021, 'Delivering personalized care and research for rare cancers in the increasingly genomic world?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500102&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P, 2021, 'Effectively communicating comprehensive tumour genomic profiling results: Mitigating uncertainty for advanced cancer patients', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 180 - 180, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500295&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomas D, 2021, 'MOST study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 91 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500101&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vatter S; Schlub TE; Napier CE; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker BB; Goldstein D; Thomas DM; Butow P, 2021, 'Psychological outcomes in advanced cancer patients after receiving genomic tumour profiling results', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 198 - 198, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500332&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page